Articles citing this paper
Design and Evaluation of the Performance of an NMR Screening Fragment Library
Bradley C. Doak A , Craig J. Morton B , Jamie S. Simpson A D and Martin J. Scanlon A C D
+ Author Affiliations
- Author Affiliations
A Medicinal Chemistry, Monash University, Parkville, Vic. 3052, Australia.
B Biota Holdings Ltd, Notting Hill, Vic. 3168, Australia.
C ARC Centre of Excellence for Coherent X-ray Science, Monash University, Parkville, Vic. 3052, Australia.
D Corresponding authors. Email: Jamie.Simpson@monash.edu; Martin.Scanlon@monash.edu
Australian Journal of Chemistry 66(12) 1465-1472 https://doi.org/10.1071/CH13280
Submitted: 31 May 2013 Accepted: 20 August 2013 Published: 7 October 2013
36 articles found in Crossref database.
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets
Zhao Guixian,
Zhu Mengping,
Li Yangfeng,
Zhang Gong, Li Yizhou
Expert Opinion on Drug Discovery. 2024 19(6). p.725
Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1
Murray James B.,
Davidson James,
Chen Ijen,
Davis Ben,
Dokurno Pawel,
Graham Christopher J.,
Harris Richard,
Jordan Allan,
Matassova Natalia,
Pedder Christopher,
Ray Stuart,
Roughley Stephen D.,
Smith Julia,
Walmsley Claire,
Wang Yikang,
Whitehead Neil,
Williamson Douglas S.,
Casara Patrick,
Le Diguarher Thierry,
Hickman John,
Stark Jerome,
Kotschy András,
Geneste Olivier, Hubbard Roderick E.
ACS Omega. 2019 4(5). p.8892
Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1
Mohanty Biswaranjan,
Rimmer Kieran,
McMahon Róisín M.,
Headey Stephen J.,
Vazirani Mansha,
Shouldice Stephen R.,
Coinçon Mathieu,
Tay Stephanie,
Morton Craig J.,
Simpson Jamie S.,
Martin Jennifer L.,
Scanlon Martin J., Driscoll Paul C.
PLOS ONE. 2017 12(3). p.e0173436
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
Arif Sheikh Mohammed,
Floto R. Andres, Blundell Tom L.
Frontiers in Molecular Biosciences. 2022 9
Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase
Mullally Christopher,
Stubbs Keith A,
Thai Van C,
Anandan Anandhi,
Bartley Stephanie,
Scanlon Martin J,
Jarvis Gary A,
John Constance M,
Lim Katherine Y L,
Sullivan Courtney M,
Sarkar-Tyson Mitali,
Vrielink Alice, Kahler Charlene M
Journal of Antimicrobial Chemotherapy. 2022 77(9). p.2441
Concepts and Experimental Protocols of Modelling and Informatics in Drug Design (2021)
Modern Magnetic Resonance (2017)
Applied Biophysics for Drug Discovery (2017)
Burger's Medicinal Chemistry and Drug Discovery (2021)
Twenty years on: the impact of fragments on drug discovery
Erlanson Daniel A.,
Fesik Stephen W.,
Hubbard Roderick E.,
Jahnke Wolfgang, Jhoti Harren
Nature Reviews Drug Discovery. 2016 15(9). p.605
Combinatorial Consensus Scoring for Ligand-Based Virtual Fragment Screening: A Comparative Case Study for Serotonin 5-HT3A, Histamine H1, and Histamine H4Receptors
Schultes Sabine,
Kooistra Albert J.,
Vischer Henry F.,
Nijmeijer Saskia,
Haaksma Eric E. J.,
Leurs Rob,
de Esch Iwan J. P., de Graaf Chris
Journal of Chemical Information and Modeling. 2015 55(5). p.1030
Fragment-Based Drug Discovery (2015)
Development of Inhibitors of Plasmodium falciparum Apical Membrane Antigen 1 Based on Fragment Screening
Lim San Sui,
Debono Cael O.,
MacRaild Christopher A.,
Chandrashekaran Indu R.,
Dolezal Olan,
Anders Robin F.,
Simpson Jamie S.,
Scanlon Martin J.,
Devine Shane M.,
Scammells Peter J., Norton Raymond S.
Australian Journal of Chemistry. 2013 66(12). p.1530
19F NMR as a Probe of Ligand Interactions with the iNOS Binding site of SPRY Domain‐Containing SOCS Box Protein 2
Leung Eleanor W. W.,
Yagi Hiromasa,
Harjani Jitendra R.,
Mulcair Mark D.,
Scanlon Martin J.,
Baell Jonathan B., Norton Raymond S.
Chemical Biology & Drug Design. 2014 84(5). p.616
Rapid Discovery of Antimicrobial and Antimalarial Agents from Natural Product Fragments
Han Jianying,
Liu Xueting,
Zhang Lixin,
Van Voorhis Wesley C.,
Quinn Ronald J., Liu Miaomiao
Separations. 2024 11(7). p.194
Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
Konaklieva Monika I., Plotkin Balbina J.
Antibiotics. 2023 12(2). p.315
Design Principles for Fragment Libraries: Maximizing the Value of Learnings from Pharma Fragment-Based Drug Discovery (FBDD) Programs for Use in Academia
Keserű György M.,
Erlanson Daniel A.,
Ferenczy György G.,
Hann Michael M.,
Murray Christopher W., Pickett Stephen D.
Journal of Medicinal Chemistry. 2016 59(18). p.8189
Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold
Devine Shane M.,
Mulcair Mark D.,
Debono Cael O.,
Leung Eleanor W. W.,
Nissink J. Willem M.,
Lim San Sui,
Chandrashekaran Indu R.,
Vazirani Mansha,
Mohanty Biswaranjan,
Simpson Jamie S.,
Baell Jonathan B.,
Scammells Peter J.,
Norton Raymond S., Scanlon Martin J.
Journal of Medicinal Chemistry. 2015 58(3). p.1205
Determination of ligand binding modes in weak protein–ligand complexes using sparse NMR data
Mohanty Biswaranjan,
Williams Martin L.,
Doak Bradley C.,
Vazirani Mansha,
Ilyichova Olga,
Wang Geqing,
Bermel Wolfgang,
Simpson Jamie S.,
Chalmers David K.,
King Glenn F.,
Mobli Mehdi, Scanlon Martin J.
Journal of Biomolecular NMR. 2016 66(3). p.195
Fragment‐based Drug Discovery Lessons and Outlook (2016)
Lead Generation (2016)
Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of EcDsbA are Atypical Substrates
Doak Bradley C.,
Whitehouse Rebecca L.,
Rimmer Kieran,
Williams Martin,
Heras Begoña,
Caria Sofia,
Ilyichova Olga,
Vazirani Mansha,
Mohanty Biswaranjan,
Harper Jason B.,
Scanlon Martin J., Simpson Jamie S.
ChemMedChem. 2024
Protein-observed 19F-NMR for fragment screening, affinity quantification and druggability assessment
Gee Clifford T,
Arntson Keith E,
Urick Andrew K,
Mishra Neeraj K,
Hawk Laura M L,
Wisniewski Andrea J, Pomerantz William C K
Nature Protocols. 2016 11(8). p.1414
Fragment-Based Drug Discovery
Norton Raymond S.
Australian Journal of Chemistry. 2013 66(12). p.1463
Antimalarial drug discovery targeting apical membrane antigen 1
Devine Shane M.,
MacRaild Christopher A.,
Norton Raymond S., Scammells Peter J.
MedChemComm. 2017 8(1). p.13
The Handbook of Medicinal Chemistry (2023)
The ways and means of fragment-based drug design
Doak Bradley C.,
Norton Raymond S., Scanlon Martin J.
Pharmacology & Therapeutics. 2016 167 p.28
Applications of 19F-NMR in Fragment-Based Drug Discovery
Norton Raymond,
Leung Eleanor,
Chandrashekaran Indu, MacRaild Christopher
Molecules. 2016 21(7). p.860
A new methodology for the synthesis of 3-amino-1H-indole-2-carboxylates
Harjani Jitendra R.,
Tang Andrew X.,
Norton Raymond S., Baell Jonathan B.
Tetrahedron. 2014 70(43). p.8047
Modern Magnetic Resonance (2018)
Fragment-Based Drug Discovery (2015)
Structural Bioinformatics: Applications in Preclinical Drug Discovery Process (2019)
Identification and characterization of two drug-like fragments that bind to the same cryptic binding pocket of Burkholderia pseudomallei DsbA
Petit Guillaume A.,
Mohanty Biswaranjan,
McMahon Róisín M.,
Nebl Stefan,
Hilko David H.,
Wilde Karyn L.,
Scanlon Martin J.,
Martin Jennifer L., Halili Maria A.
Acta Crystallographica Section D Structural Biology. 2022 78(1). p.75
Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
Chilingaryan Zorik,
Headey Stephen,
Lo Allen,
Xu Zhi-Qiang,
Otting Gottfried,
Dixon Nicholas,
Scanlon Martin, Oakley Aaron
Antibiotics. 2018 7(1). p.14
Applications of Solution NMR in Drug Discovery
Shi Li, Zhang Naixia
Molecules. 2021 26(3). p.576
Fragment-based and structure-guided discovery of perforin inhibitors
Jose Jiney,
Law Ruby H.P.,
Leung Eleanor W.W.,
Wai Dorothy C.C.,
Akhlaghi Hedieh,
Chandrashekaran Indu R.,
Caradoc-Davies Tom T.,
Voskoboinik Ilia,
Feutrill John,
Middlemiss David,
Jeevarajah Devadharshini,
Bashtannyk-Puhalovich Tanya,
Giddens Anna C.,
Lee Tet Woo,
Jamieson Stephen M.F.,
Trapani Joseph A.,
Whisstock James C.,
Spicer Julie A., Norton Raymond S.
European Journal of Medicinal Chemistry. 2023 261 p.115786
